Subscribe
Subscribe today to receive CGD’s latest newsletters and topic updates.
All Commentary
Filters:
Topics
Facet Toggle
Content Type
Facet Toggle
Blog Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
April 22, 2022
COVID-19 has reinforced the need for strong regulatory systems. The success of new technologies rapidly developed to mitigate the pandemic depends in no small part on key regulatory functions, such as oversight for clinical trials; review and authorization of medical products like vaccines, treatmen...
Blog Post
April 07, 2022
While oral antivirals are not a substitute for vaccination, they help prevent severe illness, save lives, and preserve health systems. Vaccination rates continue to lag in low-income countries: only 14 percent of the population in low-income countries has received one dose of the vaccine, compared t...
Blog Post
March 14, 2022
CGD's Javier Guzman speaks with the Indian National Health Authority's Shankar Prinja about the structure and benefits of the PMJAY insurance scheme, the challenges of large-scale programs, and the need for researchers and policymakers to work together to produce and make use of evidence on what wor...
Blog Post
February 16, 2022
One of the most prestigious HTA agencies is the National Institute for Health and Care Excellence (NICE) in England, which has gained its reputation through highly vetted, transparent, and robust processes and recommendations. For LMICs that don’t have the capacity and/or the expertise to generate t...
Blog Post
February 03, 2022
As of October 5, 2021, 15 African countries ratified the African Medicines Agency (AMA) treaty, entering into force the second specialized health agency of the African Union. The treaty struggled to get sufficient support for more than a decade after AMA was conceptualized at the 60th World Health O...